Literature DB >> 10524925

Urodynamic pattern in asymptomatic infants: siblings of children with vesicoureteral reflux.

M Bachelard1, U Sillén, S Hansson, G Hermansson, U Jodal, B Jacobsson.   

Abstract

PURPOSE: We studied the urodynamic pattern in asymptomatic infants who are siblings of children with vesicoureteral reflux.
MATERIALS AND METHODS: Cystometry and perineal electromyography were performed with voiding cystourethrography in 16 male and 21 female infant siblings screened for reflux at age 0.2 to 7.3 months (median 1.1).
RESULTS: Vesicoureteral reflux was present in 25% of the male and 10% of the female infants. In those without vesicoureteral reflux unstable bladder contractions were noted in 8% of the male and 16% of the female subjects. In these infants median maximum voiding detrusor pressure was 127 (range 84 to 211) and 72 cm. water (range 42 to 240), respectively, and median bladder capacity was 20 ml. (range 10 to 49 and 10 to 120, respectively). Maximum voiding detrusor pressure was significantly higher in male than in female infants (p <0.01). Perineal electromyography was interpretable in 13 of the 16 male and 16 of the 21 female infants overall. All but 1 female subject had increased activity during voiding, which was also present intermittently in all subjects.
CONCLUSIONS: Our study of asymptomatic siblings of children with vesicoureteral reflux has provided results that may be used as reference data for normal urodynamics in early infancy. Instability was rare. Bladder capacity was lower than expected with a predicted capacity at birth of approximately 20 ml. Maximum voiding pressure was high, especially in male subjects. The urodynamic voiding pattern suggests physiological dyscoordination, probably due to immature detrusor-sphincter function.

Entities:  

Mesh:

Year:  1999        PMID: 10524925     DOI: 10.1016/s0022-5347(05)68226-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Achieving urinary continence in children.

Authors:  Hsi-Yang Wu
Journal:  Nat Rev Urol       Date:  2010-06-08       Impact factor: 14.432

Review 2.  Vesicoureteric reflux and urinary tract infection in children.

Authors:  I Blumenthal
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

3.  Urinary bladder function in conscious rat pups: a developmental study.

Authors:  Katarina Zvarova; Peter Zvara
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-25

4.  [Fetal bladder development. A current overview].

Authors:  I Körner
Journal:  Urologe A       Date:  2007-12       Impact factor: 0.639

Review 5.  Best practice in the assessment of bladder function in infants.

Authors:  Luis Guerra; Michael Leonard; Marco Castagnetti
Journal:  Ther Adv Urol       Date:  2014-08

6.  Characteristics of the bladder in infants with urinary tract infections: an ultrasound study.

Authors:  Ji-Xian Liu; Vivian Yee-Fong Leung; Winnie Chiu-Wing Chu; Biji Sreedhar; Constantine Metreweli; Chung-Kwong Yeung
Journal:  Pediatr Radiol       Date:  2008-08-08

7.  Non-invasive evaluation of voiding function in asymptomatic primary school children.

Authors:  Hasan Serkan Dogan; Burcu Akpinar; Serhat Gurocak; Deniz Akata; Mehmet Bakkaloglu; Serdar Tekgul
Journal:  Pediatr Nephrol       Date:  2008-03-12       Impact factor: 3.714

8.  Incidence of Urinary Tract Infection Among Siblings of Children With Vesicoureteral Reflux.

Authors:  Caleb P Nelson; Jonathan A Finkelstein; Tanya Logvinenko; Mark A Schuster
Journal:  Acad Pediatr       Date:  2015-11-14       Impact factor: 3.107

Review 9.  Pediatric overactive bladder syndrome: pathophysiology and management.

Authors:  Israel Franco
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 10.  The voiding pattern in healthy pre- and term infants and toddlers: a literature review.

Authors:  Kelly Van der Cruyssen; Stefan De Wachter; Guido Van Hal; Gunter De Win; Tinne Van Aggelpoel; Alexandra Vermandel
Journal:  Eur J Pediatr       Date:  2015-06-16       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.